Skip to main content

Eksigent Nabs $2 Million ATP Grant from NIS

NEW YORK, Sept. 11 (GenomeWeb News) - Microfluidics company Eksigent Technologies won a $2 million grant from the National Institute of Standards and Technology's Advanced Technology Program, the firm said today.

 

The grant will help fund the company's ChipLC system, which is being designed to enable researchers to use high performance liquid chromatography and perform highly parallel chip-based chemical analysis.

The ATP funding will be used for a 3-year development program. Eksigent expects to commercialize intermediate-stage chip-based products during the three years.

The Scan

WHO OKs Emergency Use of Sinopharm Vaccine

The World Health Organization has granted emergency approval for Sinopharm's SARS-CoV-2 vaccine, the Guardian reports.

Scientific Integrity Panel to Meet

According to the Associated Press, a new US scientific integrity panel is to meet later this week.

Trying in the Eye

NPR reports that a study of Editas Medicine's CRISPR therapy for Leber congenital amaurosis has begun.

PLOS Papers on Cerebellum Epigenetics, Copy Number Signature Tool, Acute Lung Injury Networks

In PLOS this week: epigenetics analysis of brain tissue, bioinformatics tool to find copy number signatures in cancer, and more.